Go to content
UR Home

Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells

URN to cite this document:
DOI to cite this document:
Holzinger, Astrid ; Abken, Hinrich
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 21 Oct 2022 06:22


Background: Adoptive therapy with genetically modified T cells achieves spectacular remissions in advanced hematologic malignancies. In contrast to conventional drugs, this kind of therapy applies viable autologous T cells that are ex vivo genetically engineered with a chimeric antigen receptor (CAR) and are classified as advanced therapy medicinal products. Summary: As “living drugs,” CAR T ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -4239

Contact persons